Skip to main content
U.S. Edition
Sunday, June 13, 2021

COVID-19 vaccine

Designed to provide acquired immunity against SARS-CoV-2


COVID-19 vaccine
COVID-19 vaccine

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus causing coronavirus disease 2019 (COVID‑19). Prior to the COVID‑19 pandemic, there was an established body of knowledge about the structure and function of coronaviruses causing diseases like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), which enabled accelerated development of various vaccine technologies during early 2020. On 10 January 2020, the SARS-CoV-2 genetic sequence data was shared through GISAID, and by 19 March, the global pharmaceutical industry announced a major commitment to address COVID-19.

0 shares 1 views

News coverage

Taoiseach receives AstraZeneca vaccine

PA - Press Association STUDIO

The Taoiseach expressed hope that Ireland can look forward to a good summer as he received his first Covid-19 vaccination.Micheal..

Explore